Albert Cheung Hoi Yu, Ph.D. Albert Cheung Hoi Yu, Ph.D. Professor Infectious Disease Center, Peking University Professor and Vice-director Neuroscience.

Slides:



Advertisements
Similar presentations
Surveillance in a Pandemic: Situational Awareness
Advertisements

Keynote Address: Issues to Tackle David Nabarro Vienna Senior Officials Meeting on Avian and Pandemic Influenza 7 th June 2006.
Public health assessment Avian flu A(H5N1) situation Feb 9, 2004.
Avian Influenza A (H5N1) “Bird Flu” TRCPA November 18, 2005 Charles W. Mackett III, MD FAAFP Executive Vice Chair Department of Family Medicine University.
Epidemiological Surveillance
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
Role of the laboratory in disease surveillance
 Refers to an illness caused by any of many different strains of influenza viruses that have adapted to a specific host.  It considers as a flu.  You.
1 PUBLIC - PRIVATE PARTNERSHIP FOR AVIAN INFLUENZA CONTROL AND PANDEMIC PREPAREDNESS Presented by Bayu Krisnamurthi Indonesia National Committee for Avian.
Avian Influenza – What does it all mean? Important Background Information Island Paravets and Residents.
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
Pandemic Influenza Preparedness in Chinese Taipei Center for Disease Control Department of Health Chinese Taipei Speaker: Tsung-Hsi Wang.
Avian Influenza and Pandemic Preparedness in Thailand Department of Disease Control Ministry of Public Health Thailand.
SARS Epidemic: A Global Challenge Bong-Min Yang, PhD & Sung-il Cho, MD, PhD of School of Public Health Seoul National University.
Preparing for an Influenza Pandemic in Westminster Health and Community Services Overview and Scrutiny Committee 9 Oct 2006 Dr Margaret Guy Director of.
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.
Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.
Progress Report Global Pandemic Preparedness Beijing Conference January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative.
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
WHO COLLABORATION | September 13, | WHO Indonesia Collaboration with Animal Health.
Raymond A. Strikas, MD Associate Director for Adult Immunization Immunization Services Division National Immunization Program Coordinating Center for Infectious.
Pandemic Influenza. Guidance for Pandemic Influenza: Infection Control in Hospitals and Primary Care Settings UK Pandemic Influenza Contingency Plan Operational.
UNIVERSITY POLICE OFFICE OF EMERGENCY MANAGEMENT H1N1 Presentation.
1 WHO Communicable Diseases, Surveillance & Response SARS Diagnostics and Laboratory Needs: the WHO Perspective C.E. Roth Dangerous and New Pathogens Global.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
Planning for Pandemic Influenza Name Organization.
HHS Pandemic Influenza Preparedness Planning Julie Louise Gerberding, MD, MPH.
Avian Influenza "bird flu" Contagious disease of animals caused by viruses that normally infect only birds and pigs H5N1 can infect people (very rarely)
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
Health Security and Emergencies Ebola Response 13 October 2014.
Influenza Surveillance Danae Bixler, MD, MPH Infectious Disease Epidemiology Program.
1 OIE Response to the HPAI Threat in the SADC Region 1 st SADC Meeting on Avian Influenza Pretoria, South Africa 7-9 March 2006 Sub Regional Representation.
Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.
Text WHO Global Influenza Programme NIC Role during a pandemic and NIC contingency plan Wenqing Zhang MD Global Influenza Programme, WHO HQ THE 3rd MEETING.
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
Pandemic Response and current activities in Lao PDR NIC Meeting, Beijing, Aug 2009 Dr Phengta Vongphrachanh Director National centre for Laboratory.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Laboratory Integration in Influenza Surveillance Dr Geethani Wickramasinghe NIC- Sri Lanka.
Update: “New Flu” Activity and Community Mitigation Diane Woolard, PhD, MPH Director, Division of Surveillance and Investigation Virginia Department of.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
CONNECTICUT PANDEMIC PLANNING Meg Hooper, MPA Connecticut Department of Public Health 9 Oct 2008.
Pandemic Influenza: What Is It and Why Should We Care? Dr. Judith A. Monroe, MD State Health Commissioner.
1 Influenza Pandemic Preparedness in Thailand: Cooperation between Public and Private sectors APEC Virtual Symposium 30 May 2008 Bureau of Emerging Infectious.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Communicable Disease Surveillance and Response, WHO Avian Influenza Credit: WHO Viet Nam.
Laboratory Results and Operations in WHO Phase 6 Dr. Attaporn Taweetungtragoon CYBELES Phnom Penh, Cambodia October 12-15, 2009.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
1 |1 | Situation Update Influenza A (H1N1), 26 May 09.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
Northwest Center for Public Health Practice Before we get started with Influenza, let’s take a poll… In my opinion, the amount of media/policy attention.
Wrap-up Day 2. Plenary Four: Pandemic and avian influenza updates Pandemic H1N1 – Origin of pandemic H1N1 virus – Genetically and antigenically homogenous.
Pandemic Flu Brief Unit Name Rank / Name Unit logo.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
HEALTH FORUM GASTEIN Crisis management and health policy for SARS and influenza control EUROPEAN UNION COOPERATION ON SARS CONTROL George Gouvras Health.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Ebola preparedness and Response in Lao PDR. Outline Objective The preparedness contingency plan Phase 1: Preparedness Phase 2: Contingency for response.
SARS: International Coordination SARS: International Coordination and Collaboration James W. LeDuc, Ph.D. Director, Division of Viral and Rickettsial Diseases.
PANDEMIC H1N1 IN HANOI-VIETNAM: OVERVIEW AND RESPONSE.
1. Globalization High Mobility of Human Globalization of infectious disease outbreaks Lessons from Pandemic (H1N1) 2009 Concern of next pandemic due to.
PANDEMIC INFLUENZA M. Rony Francois, MD, MSPH, PhD
Challenges in Delivering Pandemic Vaccine from a City Health Department Perspective 43nd National Immunization Conference Fernando A. Guerra, M.D., M.P.H.
Keith Hamilton OIE Scientific and Technical Department, OIE Paris
Cedric Lazarus Livestock Development Officer
World Health Organization
The Role of NICs in Influenza Surveillance
Planning for Pandemic Influenza
Workshop on the Revised WHO Guidance
University of Washington
Presentation transcript:

Albert Cheung Hoi Yu, Ph.D. Albert Cheung Hoi Yu, Ph.D. Professor Infectious Disease Center, Peking University Professor and Vice-director Neuroscience Research Institute, Peking University Chairman and CEO Hai Kang Life Corporation Limited Beijing Hai Kang DNA Chips Limited Collaborative Opportunities on Bioinformatics in the Diagnosis of Infectious Diseases: Our Preparedness in Battle Against Avian Influenza ? 2nd ASEAN China International Bioinformatics Workshop, April 2008

Avian Influenza (AI) – A Global Threat !

 Surveillance–in man & animals  Stockpiling and logistics  Emergency responses  Public health  Community  Public communication  Coordination and command Influenza Pandemic Preparedness Plan

Phases of Alert WHOChina Very similar 6 Efficient and sustained human-to-human transmission Pandemic 5 Evidence of significant human-to-human transmission 4 Evidence of increased human-to-human transmission 3 No or very limited human-to-human transmission Pandemic Alert New virus causes human cases 2 Higher risk of human cases 1 Low risk of human cases Inter-pandemic Phase New virus in animals, no human cases Pandemic Efficient and sustained human-to-human transmission OR WHO announcement of outbreak I Human-to-human Transmission II Human infection with no human-to- human transmission III Preparatory Stage New virus isolated in humans but triggered no immune response OR immune response triggered but no symptoms IV Degree of Response

Strategy of AI Control In China National Ministry of Public Health [ With Provincial Departments of Health, Local Health Bureaus ] Provincial Medical Expert Team Provincial CDC Suspected AI Case identified in Local Hospital [by Local Medical Expert Team and Local CDC] 1.Reporting of suspected cases 2. Reporting / Delivery of sample for diagnosis & confirmation National Medical Expert Team 4.Communication, feedbacks & proposed response Direct & Real-time access to medical records through online reporting system Provide medical expert teams to support diagnosis / treatment National CDC 3. Reporting of confirmed diagnostic result Cooperation : Diagnosis and Treatment

Surveillance of AI in Animals During outbreak: Detection and report of infection by farmers and volunteer, based on clinical criteria (5% deaths in flock), to activate pre-emptive culling, confirmed by lab. (cloacal swab – viral isolation) After outbreak:  Maintenance of clinical-based surveillance with lab. testing to confirm freedom from disease in control zone around infected area for 21 days, then 5 months (OIE)  Proactive countrywide community survey to detect and destroy infected flocks, then twice a year

Detection and report of all pneumonia & flu- like illnesses with history of exposure to sick/dead poultry or of contact with pneumonia cases… Nasopharyngeal swab of all cases sent for rapid flu test, and conventional test for H5N1. Investigations of all reported cases by trained epidemiology teams. Daily situation monitoring, daily update on website. Surveillance of AI in Humans

Pandemic Planning Diagnostic Pyramid

AIV Family Tree

H5N1 viruses in 1997, 2003, 2004 and 2005 are genetically and antigenically different Different virus clades encountered in countries of the region: Clade 1 (Lao, Thailand, Vietnam, Cambodia, China) Clade 2-subclade 3 (China, Thailand, Cambodia, Vietnam) Clade 2-subclade 1 (Indonesia) Sequence variation should be considered in diagnostic development Evolving Viruses

To defeat an infectious disease, you must control its transmission from infected people to healthy ones. The critical issues are planning, surveillance, and getting an early warning. It was important to find ways to rapidly tell people that they are not infected. The Battle Against Infectious Disease

AI in China

Source: BOE, MOPH Confirmed case Suspect case Area of outbreak in poultry Jan-May 2004 Jun-April 2005 Outbreaks of AI in Poultry and Human Cases in Thailand May Dec 05

Lab Conditions No temperature control nor heating– temp in lab was about 10 o C Walls and floors did not have appropriate covering (tiles and bumpy lino) Electricity supply not guaranteed (no generator); interruptions experienced during testing No freezer below about 8 o C

Challenges for Diagnostics from Global Public Health Perspective As accurate as necessary – to ensure WHO's public health responsibilities fulfilled As quick as possible –to detect the emergence of new variants of human pandemic potential –to trigger outbreak response, investigation and rapid containment whenever needed As simple as possible –the majority of diagnostic labs in the world does not have advanced lab settings –many crucial diagnosis conducted under huge pressure

Current Detection Methods Ag / Ab-based method Microbiological evidence of virus (virus isolation) Conventional PCR Real time-PCR NASBA New Method Modified Enhanced real time-PCR Symptoms Respiratory distress syndrome X-ray evidence of lung damage Fever Virus Infection Users Where? Who? User-friendly? Affordable?

Isothermal amplification technique  comparable results within different test units Simplified operation process  reduced contamination, higher reproducibility PCR’s false positive result Amplification Technology of NASBA

Step 3. Probe hybridization Step 1. Reagent mixing Step 4. Signal detection by ELISA reader Step 2. Isothermal incubation (can be replaced by a heat block) NASBA Protocol

Adapt to regular instrument NASBA System

Participation of NASBA-EOC Detection in the Influenza Surveillance Program Commissioned by the National AIV Task Force NASBA-EOC: Takes part in the project implemented by National AIV task force Surveillance of avian influenza virus (generic and subtype H5), human influenza virus, parainfluenza virus, and other selective pneumonia-causing pathogens in Beijing population Beijing Hai Kang DNA Chips Limited provides NASBA AIV / H5 test kits for the surveillance program

National Task Force for Human AIV Training on AIV diagnosis using the NASBA EOC method to the National AIV task force members in Beijing, China

Multiplex NASBA!

Molecular Pneumonia Detection Systems Project awarded by the China Ministry of Science and Technology (a “863” project) We collaborated various hospitals in Beijing including hospitals affiliated Peking University, Chao Yang Hospital, You An Hospital and Di Tan Hospital of Capital Medical University Development of multiplex NASBA, ERT-PCR and other detection system/ technology for various pneumonia- causing pathogens (including SARS, AIV, influenza, etc.) Development of a Lab-On-A-Chip (LOAC) system

Was it possible to establish rapid and accurate tests for Infectious diseases in an outbreak situation?

Adequate clinical samples Well characterized samples are indispensable for the development and evaluation of diagnostic test Appropriate and adequate specimens Good quality Adequate clinical information Appropriate labeling and storage Good data management Difficulties in Getting Good Diagnostic Kit Validated!

Development of Sustainable and Integrated Management System 1.Development of knowledge management mechanism during the inter – pandemic period 2.Development of knowledge management mechanism during pandemic 3.Establishment of a system for coordination and communication among various organizations during pandemic 4.Coordination with foreign and international organizations 5. Monitoring and evaluation 1.Development of knowledge management mechanism during the inter – pandemic period 2.Development of knowledge management mechanism during pandemic 3.Establishment of a system for coordination and communication among various organizations during pandemic 4.Coordination with foreign and international organizations 5. Monitoring and evaluation

 Strong leadership and support of the Government  Close co-operation between public health and animal health authorities, and among partners in multi – sectors  Proactive risk communication to the public and strong public involvement  Extensive international collaborations, especially with WHO, OIE, FAO, APEC,ASEAN-China-Korea- Japan,…  Existing infrastructure (surveillance, laboratories, disease control, hospital infection, trained personnel) Major success factors for AI control

The influenza epidemic of 1918 killed 20 million in just 18 months. With 25 million Americans alone infected during the influenza epidemic, it was hard to provide care for everyone. The Red Cross, seen here with masks over the faces of the nurses, often worked around the clock. Source: Courtesy of the National Library Museum.

CNN - “Businesses brace for pandemic” 3 November 2005